Inventor · disambiguated record
Alessandra Vitelli
Also filed as: VITELLI ALESSANDRA · VITELLI ALESSANDRA FRANZ
7 granted patents·18 pending applications·4 citations·filing 2002–2024
74Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA19ANGELETTI P IST RICHERCHE BIO1CORTESE RICCARDO1OKAIROS SA1REITHERA SRL1
Top patents by PatentIndex Score
25 records- 0183US11254710B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·2 cites·12 claims
- 0280US2024075125A1Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Application pending·0 cites
- 0374US2022220157A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 0474US2024091338A1Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Application pending·0 cites
- 0573US2022204566A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 0672US11571472B2Immunogenic combinationsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Feb 7, 2023·2 cites·13 claims
- 0771US2023158134A1Chimpanzee adenovirus constructs with lyssavirus antigensGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 0870US2024382583A1Hepatitis b immunisation regimen and compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 0969US11701422B2Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Jul 18, 2023·0 cites·16 claims
- 1065US2021060150A1Novel adenovirusGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 1163US11957749B2Hepatitis B immunization regimen and compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Apr 16, 2024·0 cites·9 claims
- 1261US11254711B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·0 cites·16 claims
- 1360US2023390381A1Immunogenic combinationsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1457US2024002879A1Gorilla adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereofREITHERA SRL·Filed 2021·Application pending·0 cites
- 1554US2007259959A1Ppar Agonists for the Treatment of Hcv InfectionCORTESE RICCARDO·Filed 2004·Application pending·0 cites
- 1653US2014141042A1Expression SystemsVITELLI ALESSANDRA·Filed 2011·Application pending·0 cites
- 1753US2022112245A2Chimpanzee adenovirus constructs with lyssavirus antigensGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 1852US2018256704A1Novel Prime-Boosting Regimens Involving Immunogenic Polypeptides Encoded by PolynucleotidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 1952US2015209420A1Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotidesOKAIROS SA·Filed 2013·Application pending·0 cites
- 2051US11268108B2Replication competent adenoviral vectorsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Mar 8, 2022·0 cites·18 claims
- 2151US2017049879A1Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 2243US2021069322A1Hepatitis b immunisation regimen and compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Application pending·0 cites
- 2341US7928193B2Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replicationANGELETTI P IST RICHERCHE BIO·Filed 2005·Granted Apr 19, 2011·0 cites·6 claims
- 2441US2022305120A1Mucosal vaccine formulationsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 2536US2005019751A1Screening for hepatitis c virus entry inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alessandra Vitelli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →